Experimental Paradigm for the Assessment of the Non-pharmacological Mechanism of Action in Medical Device Classification: The Example of Glycerine as Laxative

被引:3
作者
Sardi, Claudia [1 ]
Garetto, Stefano [1 ]
Capone, Laura [2 ]
Galbiati, Valentina [3 ]
Racchi, Marco [4 ]
Govoni, Stefano [4 ]
Giovagnoni, Emiliano [2 ]
Lucci, Jacopo [1 ]
机构
[1] Nat Biomed SpA, Arezzo, Italy
[2] Aboca SpA, Soc Agr, Arezzo, Italy
[3] Univ Milan, Dept Environm Sci & Policies, Milan, Italy
[4] Univ Pavia, Dipartimento Sci Farmaco, Pavia, Italy
关键词
medical device; glycerine; lubiprostone; osmosis; laxatives; mechanism of action; CHLORIDE; LUBIPROSTONE; DISORDERS; TRANSPORT;
D O I
10.3389/fphar.2018.01410
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The evolution of medical devices has led to the introduction of medical devices that include "substances" and which, due to their presentation and sites of application may resemble medicinal products. The difference between substance-based medical devices and medicinal products lies in the proper definition of the principal mechanism of action. The major problem at the moment is the lack of a proper procedure for the demonstration of a mechanism that is "not pharmacological, immunological or metabolic." We aimed to design an experimental set up to demonstrate the difference between the mechanism of action of two substances used commonly for the treatment of constipation, lubiprostone (example of medicinal product) and glycerine (example of medical device). By implementing cellular models and molecular analyses we demonstrate the difference in their mechanism of action. This set up can be considered an example on the possibility to define a paradigm for the case by case study of the mechanism of action of substances and combination of substances in medical devices.
引用
收藏
页数:9
相关论文
共 26 条
[1]   THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: OVERVIEW [J].
Alexander, Stephen P. H. ;
Benson, Helen E. ;
Faccenda, Elena ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
McGrath, John C. ;
Catterall, William A. ;
Spedding, Michael ;
Peters, John A. ;
Harmar, Anthony J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) :1449-1458
[2]  
[Anonymous], 2005, MED DEVICES GUIDANCE
[3]  
[Anonymous], 2011, CAN J GASTROENTEROL, DOI DOI 10.1155/2011/169319
[4]  
[Anonymous], 2009, The Complete Drug Reference, Martindale
[5]   Lubiprostone Activates Cl- Secretion via cAMP Signaling and Increases Membrane CFTR in the Human Colon Carcinoma Cell Line, T84 [J].
Ao, Mei ;
Venkatasubramanian, Jayashree ;
Boonkaewwan, Chaiwat ;
Ganesan, Nivetha ;
Syed, Asma ;
Benya, Richard V. ;
Rao, Mrinalini C. .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) :339-351
[6]   Regulation of ClC-2 chloride channels in T84 cells by TGF-α [J].
Bali, MZ ;
Lipecka, J ;
Edelman, A ;
Fritsch, J .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1588-C1598
[7]   Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects [J].
Barrett, KE ;
Keely, SJ .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :535-572
[8]   Pain hypersensitivity in patients with functional gastrointestinal disorders - A gastrointestinal-specific defect or a general systemic condition? [J].
Bouin, M ;
Meunier, P ;
Riberdy-Poitras, M ;
Poitras, P .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (11) :2542-2548
[9]  
Brunton LL, 2006, Goodman and Gilman's The Pharmacological Basis of Therapeutics, V11th
[10]   Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers [J].
Camilleri, M ;
Bharucha, AE ;
Ueno, R ;
Burton, D ;
Thomforde, GM ;
Baxter, K ;
McKinzie, S ;
Zinsmeister, AR .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (05) :G942-G947